Sponsored - Product Theatre
The NHS Implant Analysis Service conducts independent physical analysis of used explanted medical devices and reports on their performance in patients. The focus of this service is to increase patient safety and drive outcome improvements.
In recent years, surgery has benefited from technological breakthroughs with the introduction of successive devices and procedures showing improved outcomes. Over time some of these innovative theoretical breakthroughs have had questionable durability in humans and some have led to catastrophic failure such as some metal on metal hip replacements and breast implants.
The UK has an enviable track record of clinical research and follow up in joint replacements. Much of this data, whilst very useful, does not include detailed physical analysis of the device performance. This service addresses the need for physical analysis and reporting whilst providing a robust, speedy service providing surgeons with an implant performance on devices removed from the human body, irrespective of the reasons for initial revision. The purpose is to provide assessment on all devices, whether the performance was as well as anticipated or not.
Jason Wilson, is the Strategy Lead for Medical Devices and Surgery working as part of the NHS Implant Analysis Service team. With over 30 years commercial experience in the medical device industry Jason has a background in major Blue Chip companies and extensive worldwide knowledge and experience in the healthcare and medical device sectors.
Having had a career working within these established Bluechip companies as well as startups and SME orthopaedic device manufacturers, Jason has a developed a great depth of knowledge of the industry. This expertise is being used to help the NHS develop and implement the system for the analysis of used medical devices.